![]() |
|
|



3
Departments of
*
Animal Science, Food and Nutrition and
Physiology, Southern Illinois University, Carbondale, IL 62901
3To whom correspondence should be addressed.
Soy protein diets lower plasma cholesterol in hyperlipoproteinemic
human subjects, as well as in animal models. We fed 7-wk-old male obese
(fa/fa) and lean Zucker rats a modified AIN-76 diet (20
g protein/kg diet) containing casein (C), low isoflavone soy protein
(38 mg isoflavones/kg diet; LI), or high isoflavone soy protein (578 mg
isoflavones/kg diet; HI) for 70 d. In obese rats, plasma total
cholesterol was 21 and 29% lower in the LI and HI groups,
respectively, than in the C group (P
0.004).
Liver weight and liver triglyceride and cholesteryl ester
concentrations were 27, 33 and 46% lower, respectively, in the LI
group than in the C group (P < 0.003). These liver
measurements were 23, 24 and 57% lower, respectively, in the HI group
than in the LI group (P < 0.05). In a
complementary study, 5-wk-old male Sprague-Dawley rats were fed the
same C, LI and HI diets for 42 d. Thrombin-mediated platelet
serotonin release in vitro was 13% lower in the HI group than in the C
group (P = 0.003). In a third study, 7-wk-old male
Sprague-Dawley rats were fed either a modified AIN-76 control diet
or a high fat casein-based atherogenic diet (140 g fat, 12 g
cholesterol, and 2 g cholic acid/kg diet) with or without a soy
isoflavones extract (983 mg isoflavones/kg diet) for 63 d.
Addition of the isoflavones extract to the atherogenic diet lowered the
liver triglyceride concentration by 33% relative to the atherogenic
diet without isoflavones (P = 0.0001). Our studies
suggest that the hypocholesterolemic mechanism of dietary soy protein
involves a cooperative interaction between the protein and
isoflavone-enriched fraction that lowers hepatic lipid
concentrations. We speculate that modulation of liver and plasma lipid
homeostasis can also lower blood platelet sensitivity.
KEY WORDS: soy protein soy isoflavones rats hepatic lipids platelets
This article has been cited by other articles:
![]() |
A. Orgaard and L. Jensen The Effects of Soy Isoflavones on Obesity Experimental Biology and Medicine, September 1, 2008; 233(9): 1066 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Peluso Flavonoids Attenuate Cardiovascular Disease, Inhibit Phosphodiesterase, and Modulate Lipid Homeostasis in Adipose Tissue and Liver Experimental Biology and Medicine, September 1, 2006; 231(8): 1287 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ferrari, M. Arnold, R. D. Carr, W. Langhans, G. Pacini, T. B. Bodvarsdottir, and D. X. Gram Subdiaphragmatic vagal deafferentation affects body weight gain and glucose metabolism in obese male Zucker (fa/fa) rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1027 - R1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Song, S.-O. Lee, P. A. Murphy, and S. Hendrich Soy Protein With or Without Isoflavones, Soy Germ and Soy Germ Extract, and Daidzein Lessen Plasma Cholesterol Levels in Golden Syrian Hamsters Experimental Biology and Medicine, October 1, 2003; 228(9): 1063 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Mezei, W. J. Banz, R. W. Steger, M. R. Peluso, T. A. Winters, and N. Shay Soy Isoflavones Exert Antidiabetic and Hypolipidemic Effects through the PPAR Pathways in Obese Zucker Rats and Murine RAW 264.7 Cells J. Nutr., May 1, 2003; 133(5): 1238 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.J. Iqbal, S. Yaegashi, R. Ahsan, D.A. Lightfoot, and W.J. Banz Differentially abundant mRNAs in rat liver in response to diets containing soy protein isolate Physiol Genomics, December 3, 2002; 11(3): 219 - 226. [Abstract] [Full Text] [PDF] |
||||